SCHF

(redirected from Severe Chronic Heart Failure)
AcronymDefinition
SCHFSouthern California Homebrewer's Festival
SCHFSquamous Cell Hyperplastic Foci
SCHFSevere Chronic Heart Failure (cardiology)
SCHFSevere Congestive Heart Failure (cardiology)
SCHFSunrise Children’s Hospital Foundation
References in periodicals archive ?
Also in the trial, 102 randomized subjects with less severe chronic heart failure found benefit in lowering levels of a biomarker that measures heart failure.
Only 30% of moderate to severe chronic heart failure patients are candidates for CRT.
All suffer from severe chronic heart failure, both due to the after effects of heart attacks and inherited conditions.
Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol.
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344 : 1651-8.
Interval training in patients with severe chronic heart failure: analysis and recommendations for exercise procedures.
Cheetham C, Green D, Collis J, Dembo L, O'Driscoll G (2002) Effect of aerobic and resistance exercise on central hemodynamic responses in severe chronic heart failure. Journal of Applied Physiology 93: 175-180.
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. J Heart Lung Transplant 2006; 25:1241-6.
The first generic formulations of the [beta]-blocker carvedilol (Coreg) have been approved by the Food and Drug Administration for treating hypertension, mild to severe chronic heart failure, and left ventricular dysfunction following a myocardial infarction in clinically stable patients.
The first generic formulations of the beta-blocker carvedilol (Coreg) have been approved by the Food and Drug Administration for treating hypertension, mild to severe chronic heart failure, and left ventricular dysfunction following a myocardial infarction in clinically stable patients.
Coreg is a widely used medication that is FDA-approved to treat high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following a heart attack.
Treatment with the beta-blocker carvedilol may make it possible for some children with severe chronic heart failure to avoid the need for cardiac transplantation, according to a study conducted by researchers at the University of Sao Paulo Medical School in Brazil.
Full browser ?